文献速递重症综合管理与镇静镇痛

耳声发射检测用于识别ICU患者听力损失:一项可行性研究

Otoacoustic Emissions Testing to Identify Hearing Loss in the ICU: A Feasibility Study.
PubMed 文献 · Crit Care Explor · 2025-03-03
一句话结论在医疗ICU中,耳声发射检测筛查听力损失可行,23例中74.2%完成测试,每耳平均耗时152.6秒,18例完整数据中6例筛查阳性。

本研究为试点研究,在三级医疗中心医疗ICU于2021年11月29日至12月3日纳入所有年龄≥18岁成人,评估使用耳声发射(OAE)检测筛查ICU患者既存听力损失的可行性。OAE为非侵入性、非参与性工具,检测6个频率(1k、1.5k、2k、3k、4k赫兹)的耳蜗内运动。主要可行性终点为先验定义的完成至少70%尝试测试;31例中23例(74.2%)接受测试,8例(25.8%)无法测试,最常见原因为环境噪声升高。18例完整数据中6例筛查阳性;每耳平均测试完成时间152.6秒(sd=97.6秒)。作者认为OAE是ICU筛查听力损失的可行方法,未来研究应评估识别和治疗听力损失是否可减少谵妄并改善ICU后恢复。

要点

  • 在医疗ICU成人中,OAE筛查听力损失可行:31例中23例(74.2%)完成测试,达到先验定义的≥70%完成率。
  • 8例(25.8%)无法测试,最常见原因为环境噪声升高。
  • 18例完整数据中6例筛查阳性(至少2/6频率在至少一耳检出即通过,提示无中重度听力障碍)。
  • 每耳OAE测试平均耗时152.6秒(sd=97.6秒)。
  • 作者认为OAE是ICU筛查听力损失的可行方法,包括非参与性患者;未来研究应评估识别和治疗听力损失是否可减少谵妄并改善ICU后恢复。

适用人群与场景

  • 所有年龄≥18岁且于2021年11月29日至2021年12月3日收入医疗ICU的成人均符合纳入标准。
  • 研究在三级医疗中心的医疗ICU进行。

诊断标准与关键阈值

  • 通过标准:至少2/6频率在至少一耳检出OAE,提示无中重度听力障碍(无需放大器)。
  • 测试频率:1k、1.5k、2k、3k、4k赫兹。

处置流程与药物剂量

  • OAE为非侵入性、非参与性工具,通过检测听觉刺激引起的耳蜗内运动筛查听力损失。
  • 测试6个频率(1k、1.5k、2k、3k、4k赫兹)的OAE存在与否。
  • 筛查阳性者可通过放大器及环境调整等干预改善沟通。

研究设计与关键结果

  • 研究类型:试点研究;样本量:31例尝试,23例(74.2%)接受测试,8例(25.8%)无法测试,最常见原因为环境噪声升高;18例有完整数据。
  • 主要可行性终点:完成至少70%尝试测试,实际完成74.2%。
  • 18例完整数据中6例筛查阳性。
  • 每耳OAE测试平均完成时间152.6秒(sd=97.6秒)。

证据类型、等级与局限

  • 证据类型:试点研究(单中心医疗ICU)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为OAE测试是ICU筛查听力损失的可行方法,包括非参与性患者。
  • 作者认为识别听力损失有助于通过放大器及环境调整等干预改善沟通。
  • 未来研究应评估识别和治疗ICU听力损失是否可减少谵妄并改善ICU后恢复(作者建议)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Hearing impairment is associated with delirium among ICU patients and a lack of functional recovery among older ICU survivors. We assessed the feasibility of using otoacoustic emissions (OAEs) testing to screen for preexisting hearing loss in the ICU.

DESIGN: Pilot study.

SETTING: Medical ICU at a tertiary medical center.

PATIENTS: All adults (age ≥ 18) and admitted to the medical ICU between November 29, 2021, and December 03, 2021, were eligible for the study.

INTERVENTIONS: OAE is a noninvasive, nonparticipatory tool that is used to screen for hearing loss by detecting intracochlear motion in response to auditory stimulation. The presence or absence of OAE was tested at six frequencies (1 k, 1.5 k, 2 k, 3 k, 4 k hertz).

MEASUREMENTS AND MAIN RESULTS: The primary outcome of feasibility was defined a priori as completion of greater than or equal to 70% of attempted tests. Average time of test completion and barriers or facilitators were also measured as outcomes. A patient passed OAE testing if at least two of six frequencies were detected in at least one ear, suggesting they did not have moderate or severe hearing impairment (that would require an amplifier). Data were also gathered on demographics, delirium, ventilation, sedation, illness severity, and ambient noise. Of 31 patients approached, 23 (74.2%) underwent testing. Eight patients (25.8%) were unable to be tested, most commonly due to elevated ambient noise. Among the 18 patients with complete data, six patients screened positive for hearing loss. The average time for OAE test completion per ear was 152.6 seconds (sd = 97.6 s).

CONCLUSIONS: OAE testing is a feasible method to screen for hearing loss in the ICU, including in nonparticipatory patients. Identification of hearing loss would facilitate improved communication through interventions such as amplifiers and accommodations. Future studies should evaluate whether identification and treatment of hearing loss in the ICU may reduce delirium and improve post-ICU recovery.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Kaushik R, Reed N, Ferrante LE, et al. Otoacoustic Emissions Testing to Identify Hearing Loss in the ICU: A Feasibility Study. Crit Care Explor. 2025. PMID: 40028925. doi:10.1097/CCE.0000000000001223

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。